At ASMS 2009, Bruker Introduces Three Major New High-Performance Mass Spectrometry Platforms and Advances Its Applied Proteomics Solutions

PHILADELPHIA--(Business Wire)--
At the 57th ASMS Conference on Mass Spectrometry and Allied Topics
(www.asms.org), Bruker Daltonics today launches three completely new, major
high-performance mass spectrometry platforms for life-science applications in
proteomics, small molecule research and applied markets, as well as in clinical
research and IVD applications. With the unprecedented introduction of three
major new mass spec product lines, and very significant advances in its applied
proteomics solutions, Bruker Daltonics is embarking on a bold mission to set new
performance and application standards in many areas of life-science mass
spectrometry.

At ASMS 2008, Bruker launched its unique high-speed Ultra-High Resolution TOF
(UHR-TOF) mass spectrometer, called maXis, which has become a very successful
highest performance, no-compromise system for proteomics and small molecule
applications with a large number of installations in many leading pharmaceutical
and academic laboratories. At ASMS 2009, Bruker launches three all-new, truly
innovative major mass spectrometry platforms, each of which has been announced
with a dedicated, detailed press release in recent weeks:

* ultrafleXtremeTMis the only fully 1,000 Hz MS and MS/MS enabled MALDI-TOF/TOF
system, and incorporates proprietary new smartbeam-II laser technology and a 4
GHz digitizer. Its proteomics performance is unmatched with broad-band mass
resolving power up to 40,000 and 1 ppm mass accuracy. Arapidly self-cleaning ion
source, industry-leading imaging software and laser focus diametersdown to 10 µm
make it ideal for MALDI imaging. Its unprecedented flexibility allows LC-MALDI
TOF/TOF proteomics, quantitative label-free proteomics, MALDI imaging, top-down
proteomics, Edmass protein sequencing, intact protein analysis, polymer research
and oligonucleotide analysis. For further information:
www.bdal.com/ultrafleXtreme
* amaZonTMis the fastest ion trap mass spectrometer in the world today with
52,000 u/second scan rate at 0.58 u mass resolution, and rapid zero-delay
polarity switching 20 Hz MS acquisition when coupled to UHPLC fast
chromatography systems. Due to its novel proprietary dual ion funnel technology
it offers an order of magnitude jump in sensitivity. Second-Generation ETD and
PTR options for proteomics offer unmatched ETD sensitivity due to its elegant,
uncomplicated design. Ultimate ion trap mass resolving power up to 20,000 in
full scan mode across the 50-3000 m/z range that is fast enough to be useable at
LC speeds, make real-world LC top-down ETD experiments a reality. Its
outstanding full-scan MS speed and MS/MS sensitivity allow it to obsolete many
triple-quadrupole MRM methods for rapid quantitation of large target analyte
lists in applied markets from toxicology, food safety, doping and forensics. For
further information: www.bdal.com/amaZon
* solariXTMoffers a 10-fold improvement in FTMS sensitivity, an 8-fold gain in
broadband ultra-high resolution of >1,000,000 at 7 Tesla, and sub-ppm mass
accuracy over a wide dynamic range. A complete engineering redesign makes this
instrument extremely robust, consistent and easy to use. It is ideal for the
analysis of very complex mixtures in top-down proteomics (including ETD and ECD
now), petroleomics, metabolomics, and small-molecule drug and metabolite MALDI
imaging. For further information: www.bdal.com/solariX

In addition to its new product launches, at ASMS 2009 Bruker Daltonics is also
further advancing various applied proteomics solutions, leveraging its
leadership in MALDI mass spectrometry:

* The revolutionary, top-down EdmassTM protein sequencing solution offers a much
faster, more powerful and convenient next-generation protein sequencing solution
for all biologists and life-science researchers.
* Bruker's well established MALDI Biotyper solution for microbial identification
in clinical microbiology has recently obtained an IVD-CE mark with a Declaration
of Conformity in accordance with the European Union In Vitro Diagnostic
Directive 98/79/EC. The MALDI Biotyper offers faster time to result, lower
consumables costs, and higher specificity. It has the potential to become the
new `gold standard` in clinical microorganism identification (for research use
only outside the European Union).

* Carl Zeiss` MIRAX Virtual Slide Scanner and Bruker's MALDI Molecular ImagerTM
now enable non-targeted molecular histology with high spatial resolution in an
integrated solution (research use only) for biological tissue research and
clinical pathology research.

The new Bruker mass spectrometry products and applications will be presented
throughout the ASMS conference at a number of venues and events: three ASMS
lunch-time technical workshops are planned for Monday, Tuesday and Wednesday in
the Philadelphia Marriott Downtown Hotel Room Franklin 7. Starting promptly at
12 noon, the one hour workshops will be open to the scientific press. Scientists
and journalists can register at www.bdal.com/asms2009 .

Bruker Daltonics staff will be available for in-depth meetings during exhibit
hours at Bruker's booth (no. 68), and Monday through Wednesday evening from 6:30
to 9:30 p.m. in the Bruker Hospitality Suite at the Philadelphia Marriott
Downtown Hotel Room Franklin 7. At 7:00 p.m. each evening, there will be special
receptions and "launch parties" in the Hospitality Suite for the market
introduction of the new solariX, amaZon and ultrafleXtreme systems.

Bruker will also host a press conference starting at 11:00 a.m. in the
Philadelphia Convention Center Room 108A. Journalists and editors of scientific
and trade journals are invited to attend this special press conference to learn
more about Bruker Daltonics` new Mass Spectrometry products.

ABOUT BRUKER DALTONICS: For more information about Bruker Daltonics and Bruker
Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.

Bruker Daltonics
Darwin Asa, Ph.D., +1 978 663-3660, ext. 1149
Life-Science Marketing Manager
dja@bdal.com

Copyright Business Wire 2009